Carlevale眼内镜巩膜固定:系统综述与Meta分析
该研究通过系统综述与Meta分析评估无缝线巩膜固定Carlevale眼内镜植入术后的手术及屈光结局。13项研究550眼的Meta分析显示最佳矫正视力(BCVA)显著改善(WMD=0.38,95%CI 0.30-0.46,P<0.001)。16项研究608眼的术后并发症汇总发生率为0.22(95%CI 0.13-0.32)。
要点
- Carlevale眼内镜植入术后BCVA显著改善,WMD=0.38(95%CI 0.30-0.46,P<0.001)
- 术后并发症汇总发生率为0.22(95%CI 0.13-0.32,I²=84.87,P≤0.001)
- 结论认为Carlevale眼内镜是恢复无囊膜或悬韧带支撑眼视力的可靠方法
核心结论
- Carlevale眼内镜植入是恢复无囊膜或悬韧带支撑眼视力的可靠方法。
研究设计与样本
- 系统综述与Meta分析,文献检索PubMed、Embase和Scopus。
- BCVA、眼压和内皮细胞计数的Meta分析纳入13项研究共550眼。
- 术后并发症发生率的Meta分析纳入16项研究共608眼。
主要发现
- BCVA平均变化汇总WMD=0.38(95%CI 0.30-0.46,P<0.001;异质性I²=52.02%),显示显著改善。
- 亚组分析显示BCVA平均变化按末次随访时间无显著亚组效应(P=0.21):随访至6个月WMD=0.34(95%CI 0.23-0.45,I²=58.32%),随访至24个月WMD=0.42(95%CI 0.34-0.51,I²=38.08%)。
- 术后并发症汇总发生率为0.22(95%CI 0.13-0.32,I²=84.87,P≤0.001)。
关键数值与推荐
- BCVA改善:WMD=0.38(95%CI 0.30-0.46,P<0.001),异质性I²=52.02%。
- 并发症发生率:0.22(95%CI 0.13-0.32),异质性I²=84.87,P≤0.001。
局限性
- BCVA分析异质性I²=52.02%。
- 并发症分析异质性I²=84.87。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The mean change in best-corrected visual acuity (BCVA), intraocular pressure, and endothelial cell counts after intraocular lens (IOL) implantation and the incidence rate of postoperative complications were estimated by systematic review and meta-analysis to assess the surgical and refractive outcomes of the sutureless scleral fixation Carlevale IOL. METHODS: A literature search was conducted using PubMed, Embase, and Scopus. The weighted mean difference (WMD) was used to present the mean change in BCVA, intraocular pressure, and endothelial cell count after IOL implantation, whereas a proportional meta-analysis was used to estimate the pooled incidence rate of postoperative complications. RESULTS: In the meta-analysis of 13 studies involving 550 eyes, the pooled WMD of the mean change in BCVA showed a significant improvement in BCVA in patients who underwent Carlevale IOL implantation (WMD = 0.38, 95% confidence interval: 0.30-0.46, P < 0.001; heterogeneity [I 2 ] = 52.02%). The subgroup analyses indicated that the mean change in BCVA was not significantly higher according to the last follow-up visit, with no statistically significant subgroup effect ( P = 0.21) (WMD up to 6 months: 0.34, 95% confidence interval: 0.23-0.45, I 2 = 58.32%, WMD up to 24 months: 0.42, 95% confidence interval: 0.34-0.51, I 2 = 38.08%). In the meta-analysis of 16 studies involving 608 eyes, the pooled incidence rate of postoperative complications was equal to 0.22 (95% confidence interval: 0.13-0.32, I 2 = 84.87, P ≤ 0.001). CONCLUSION: Carlevale IOL implantation represents a reliable method of restoring vision in eyes with missing capsular or zonular support.
引用
- Ripa M, Angunawela R, Motta L, et al. SCLERAL FIXATION OF CARLEVALE INTRAOCULAR LENS: A Systematic Review and Meta-Analysis. Retina. 2023. PMID: 37399540. doi:10.1097/IAE.0000000000003873
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。